A quarter of the patients of the heart are re-hospitalized or to die in 6 months

tolokonov/epictura

Published the 19.01.2018 at 16h12

A A

Keywords :

failure coronaireinsuffisance cardiaquehospitalisationdécès

Six months after their first hospitalization, nearly a quarter of patients with a disease of the coronary, chronic (” chronic ischemic heart disease “) are dead or re-admitted to the hospital. This result, from a study conducted by the european Society of cardiology, may, however, be avoided because it is linked to a poor monitoring of the treatment.

Coronary heart disease which leads to heart failure

Ischemic heart disease is a heart attack related to coronary arteries partially clogged, which does not bring enough oxygenated blood in the heart muscle. It is manifested by a coronary insufficiency and heart.
The study is based on the monitoring data of 2 203 patients, from 10 european countries, with these two types of inadequacies.
Six months after their first appointment at the hospital for this pathology, 522 people died or were re-hospitalized. And this, mostly due to a cardiovascular event. These patients were generally older and had a history of revascularization device, chronic renal failure, or chronic obstructive pulmonary disease.

Almost 35 000 deaths in France

“We have identified clinical factors associated with these risks of death and re-hospitalizations,” says Michel Komajda, a cardiologist at the Pitié-Salpétrière in Paris and professor at the University Pierre and Marie Curie. After the first appointment at the hospital, the patients have a prescription and take the recommended drugs. Six months later, however, the rate of prescription of these same treatments decreases : the sick are treated less as at the beginning and increase the risk of complications.
“It is possible that it does not return enough of these patients to a cardiologist or a general practitioner, and that their prescriptions are therefore not renewed,” says Michel Komajda.
Lack of medical follow-up, refusal or inability of taken treatments for the patients… the reasons for the reduction of the monitoring requirements may be multiple, but the consequences remain the same.

In France, 34 870 people died of ischemic heart disease in 2011.